Skip to main content

Advertisement

SpringerLink
Log in

Average lifespan shortened due to breast cancer in Australia, 1990–2015

  • Rapid Communication
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

This short report aims to investigate changes in lifespan of Australian women with breast cancer using the novel average lifespan shortened (ALSS) measure

Methods

We obtained the mortality data of Australian women with breast cancer from the World Health Organization mortality database for the 1990–2015 period. We calculated the age-standardized rate (ASR) according to the World Standard Population. We estimated the ALSS as a ratio of years of life lost in relation to the expected lifespan to examine changes in lifespan of Australian women with breast cancer over the study period.

Results

Over a 25-year period, the ASR of breast cancer deaths decreased from 20.5 to 12.6 deaths per 100,000 women. We observed a decline in ALSS values from 24.0% of their lifespan in 1990 to 22.0% in 2015.

Conclusion

The novel ALSS measure indicates an improvement of two percentage points in the lifespan of Australian women with breast cancer over the study

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pham TM, Sikdar KC, Cheung WY, Roa W, Eckstrand A, Kaposhi B, et al. Premature mortality due to malignancies of the central nervous system in Canada, 1980–2010. Neuroepidemiology. 2018;50:195–200.

    Article  Google Scholar 

  2. Pham TM, Sikdar KC, Kaposhi B, Lupichuk S, Yang H, Shack L. Premature mortality due to breast cancer among Canadian women: an analysis of a 30-year period from 1980 through 2010. Eur J Public Health. 2018;28:348–52.

    Article  Google Scholar 

  3. Pham TM, Shack L, Cheung WY. Introduction of a novel measure of premature mortality caused by chronic conditions: real-world examples from prostate and testis cancers in Canada, 1980–2015. Ann Epidemiol. 2019;37:81–3.

    Article  Google Scholar 

  4. Atchison KM, Pham TM, Sikdar KC, Weeks LA, Karosas APV, Sinnarajah A, et al. Premature deaths due to head and neck cancers in Canada: a nationwide analysis from 1980 to 2010. Laryngoscope. 2020;130:911–7.

    Article  Google Scholar 

  5. Pham TM, Shen-Tu G, Nguyen KH, Lu S, Dover DC, Duggan P, et al. Premature mortality due to hodgkin lymphoma, non-hodgkin lymphoma, multiple myeloma, and leukemia in Canada: a nationwide analysis from 1980 to 2015. Am J Epidemiol. 2021;190:59–75.

    Article  Google Scholar 

  6. Pham TM, Thanh NX, Wasylak T, Hill MD, Jeerakathil T, Sikdar KC, et al. Average lifespan shortened due to stroke in Canada: a nationwide descriptive study from 1990 to 2015. Stroke. 2021;52:573–81.

    Article  CAS  Google Scholar 

  7. Pham TM, Kubo T, Fujino Y, Fujimoto N, Tomisaki I, Minato A, et al. Premature mortality due to malignancies of the kidney and bladder in Japan, 1980–2010. J Epidemiol. 2019;29:464–70.

    Article  Google Scholar 

  8. Pham TM, Quy PN, Horimatsu T, Muto M, Shack L, Cheung WY, et al. Premature mortality due to stomach cancer in Japan: a nationwide analysis from 1980 to 2015. Ann Epidemiol. 2020;47:19–24.

    Article  Google Scholar 

  9. Morrell S, Taylor R, Roder D, Dobson A. Mammography screening and breast cancer mortality in Australia: an aggregate cohort study. J Med Screen. 2012;19:26–34.

    Article  Google Scholar 

  10. Nickson C, Velentzis LS, Brennan P, Mann GB, Houssami N. Improving breast cancer screening in Australia: a public health perspective. Public Health Res Pract. 2019;29:e2921911.

    Article  Google Scholar 

  11. Pharmaceutical Benefits Advisory Committee Australia: Public Summary Document–November 2014 PBAC Meeting, 2014.

  12. Parkinson B, Viney R, Haas M, Goodall S, Srasuebkul P, Pearson S-A. Real-world evidence: a comparison of the Australian herceptin program and clinical trials of trastuzumab for her2-positive metastatic breast cancer. Pharmacoeconomics. 2016;34:1039–50.

    Article  Google Scholar 

Download references

Acknowledgements

We are grateful to the WHO and sincerely thank their staff for their efforts in collecting and monitoring the mortality database. The content in this article is solely responsibility of the authors and the views of authors do not necessarily represent those of their affiliated organizations.

Author information

Authors and Affiliations

  1. Surveillance and Reporting, Cancer Research and Analytics, Cancer Care Alberta, Alberta Health Services, Edmonton, Canada

    Truong-Minh Pham & Mohammadreza Pakseresht

  2. Robinson Research Institute, The University of Adelaide, Adelaide, Australia

    Dang Kien Nguyen & Sean O’Leary

  3. Andrology and Fertility Hospital of Hanoi, Hanoi, Vietnam

    Hanh My Pham

  4. Faculty of Public Health, Thai Binh University of Medicine and Pharmacy, Thaibinh, Vietnam

    Duc-Cuong Le

  5. Advanced Analytics, Cancer Research and Analytics, Cancer Care Alberta, Alberta Health Services, Calgary, Canada

    Lorraine Shack

  6. Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada

    Winson Y. Cheung

Authors
  1. Truong-Minh Pham
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dang Kien Nguyen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hanh My Pham
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Duc-Cuong Le
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mohammadreza Pakseresht
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lorraine Shack
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Winson Y. Cheung
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sean O’Leary
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Truong-Minh Pham.

Ethics declarations

Competing interests

None declared.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pham, TM., Nguyen, D.K., Pham, H.M. et al. Average lifespan shortened due to breast cancer in Australia, 1990–2015. Breast Cancer 28, 1389–1391 (2021). https://doi.org/10.1007/s12282-021-01271-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-021-01271-8

Keywords

Search

Navigation